These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Future of hepatitis C therapy: development of direct-acting antivirals. Dore GJ; Matthews GV; Rockstroh J Curr Opin HIV AIDS; 2011 Nov; 6(6):508-13. PubMed ID: 21897228 [TBL] [Abstract][Full Text] [Related]
3. Future perspectives: towards interferon-free regimens for HCV. Gane E Antivir Ther; 2012; 17(6 Pt B):1201-10. PubMed ID: 23186654 [TBL] [Abstract][Full Text] [Related]
4. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents. Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C therapy: Looking toward interferon-sparing regimens. Au TH; Destache CJ; Vivekanandan R J Am Pharm Assoc (2003); 2015; 55(2):e72-84; quiz e85-6. PubMed ID: 25658389 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus: standard-of-care treatment. Pawlotsky JM Adv Pharmacol; 2013; 67():169-215. PubMed ID: 23886001 [TBL] [Abstract][Full Text] [Related]
7. [Hepatitis C therapy: a problem almost solved]. Rizzetto M Recenti Prog Med; 2014 Jun; 105(6):225-6. PubMed ID: 25002283 [TBL] [Abstract][Full Text] [Related]
9. The changing therapeutic landscape for hepatitis C. Dore GJ Med J Aust; 2012 Jun; 196(10):629-32. PubMed ID: 22676877 [TBL] [Abstract][Full Text] [Related]
10. Management of hepatitis C infection before and after liver transplantation. Fagiuoli S; Ravasio R; LucĂ MG; Baldan A; Pecere S; Vitale A; Pasulo L World J Gastroenterol; 2015 Apr; 21(15):4447-56. PubMed ID: 25914454 [TBL] [Abstract][Full Text] [Related]
11. Direct-acting antiviral drugs for the treatment of chronic hepatitis C virus infection: Interferon free is now. Florian J; Mishra P; Arya V; Harrington P; Connelly S; Reynolds KS; Sinha V Clin Pharmacol Ther; 2015 Oct; 98(4):394-402. PubMed ID: 26179495 [TBL] [Abstract][Full Text] [Related]
12. Nanomedicine as a future therapeutic approach for Hepatitis C virus. Abd Ellah NH; Tawfeek HM; John J; Hetta HF Nanomedicine (Lond); 2019 Jun; 14(11):1471-1491. PubMed ID: 31166139 [TBL] [Abstract][Full Text] [Related]
13. Telaprevir: changing the standard of care of chronic hepatitis C. Rajani AK; Ravindra BK; Dkhar SA J Postgrad Med; 2013; 59(1):42-7. PubMed ID: 23525057 [TBL] [Abstract][Full Text] [Related]
15. ABT-450/ ritonavir and ABT-267 in combination with ABT-333 for the treatment of hepatitis C virus. Minaei AA; Kowdley KV Expert Opin Pharmacother; 2015 Apr; 16(6):929-37. PubMed ID: 25800085 [TBL] [Abstract][Full Text] [Related]
16. Current and Evolving Treatments of Genotype 1 Hepatitis C Virus. Alqahtani S; Sulkowski M Gastroenterol Clin North Am; 2015 Dec; 44(4):825-43. PubMed ID: 26600222 [TBL] [Abstract][Full Text] [Related]
17. Are statins a viable option for the treatment of infections with the hepatitis C virus? Verpaalen B; Neyts J; Delang L Antiviral Res; 2014 May; 105():92-9. PubMed ID: 24613180 [TBL] [Abstract][Full Text] [Related]
18. [Antiviral treatment of chronic hepatitis C]. Berger A Med Monatsschr Pharm; 2012 Feb; 35(2):55-60. PubMed ID: 22400430 [TBL] [Abstract][Full Text] [Related]
19. Current progress in the treatment of chronic hepatitis C. Alexopoulou A; Papatheodoridis GV World J Gastroenterol; 2012 Nov; 18(42):6060-9. PubMed ID: 23155334 [TBL] [Abstract][Full Text] [Related]
20. What does the pharmacological future of treating chronic hepatitis C look like? Heil EL; Hynicka LM; Kottilil S; Tang L Expert Rev Clin Pharmacol; 2015; 8(5):605-22. PubMed ID: 26289223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]